These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24736876)

  • 21. Illness perceptions predict health practices and mental health following hematopoietic stem cell transplantation.
    Nelson AM; Juckett MB; Coe CL; Costanzo ES
    Psychooncology; 2019 Jun; 28(6):1252-1260. PubMed ID: 30942921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].
    Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
    Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Bregante S; Berisso G; Mordini N; Incagliato M; Fugazza G; Sessarego M; Bacigalupo A
    Haematologica; 1998 Oct; 83(10):896-903. PubMed ID: 9830798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.
    McDonald GB; Sandmaier BM; Mielcarek M; Sorror M; Pergam SA; Cheng GS; Hingorani S; Boeckh M; Flowers MD; Lee SJ; Appelbaum FR; Storb R; Martin PJ; Deeg HJ; Schoch G; Gooley TA
    Ann Intern Med; 2020 Feb; 172(4):229-239. PubMed ID: 31958813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation.
    Ishikawa A; Otaka Y; Kamisako M; Suzuki T; Miyata C; Tsuji T; Matsumoto H; Kato J; Mori T; Okamoto S; Liu M
    Support Care Cancer; 2019 May; 27(5):1793-1800. PubMed ID: 30155567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of pre-transplant disease burden on the outcome of allogeneic hematopoietic stem cell transplant in refractory and relapsed acute myeloid leukemia: a single-center study.
    Tian H; Chen GH; Xu Y; Ma X; Chen F; Yang Z; Jin ZM; Qiu HY; Sun AN; Wu DP
    Leuk Lymphoma; 2015 May; 56(5):1353-61. PubMed ID: 25204372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
    Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
    J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
    Friend BD; Bailey-Olson M; Melton A; Shimano KA; Kharbanda S; Higham C; Winestone LE; Huang J; Stieglitz E; Dvorak CC
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28079. PubMed ID: 31724815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival.
    El-Ghammaz AMS; Ben Matoug R; Elzimaity M; Mostafa N
    Support Care Cancer; 2017 Oct; 25(10):3085-3093. PubMed ID: 28439725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT.
    Frankiewicz A; Peczynski C; Giebel S; Harrington A; Socié G; Niederwieser D; Scheid C; Bornhäuser M; Kröger N; Elmaagacli A; Afanasyev B; Dreger P; Rössig C; Blaise D; Kratz C; Yakoub-Agha I; Kremens B; Niemeyer CM; Wulf G; Blau I; Penack O; Greinix H; Basak GW
    Front Immunol; 2020; 11():1537. PubMed ID: 32793210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation.
    Harashima S; Yoneda R; Horie T; Fujioka Y; Nakamura F; Kurokawa M; Yoshiuchi K
    Bone Marrow Transplant; 2019 Jul; 54(7):1013-1021. PubMed ID: 30353064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
    Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B
    Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
    Fingrut W; Law A; Lam W; Michelis FV; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
    Ann Hematol; 2021 Mar; 100(3):789-798. PubMed ID: 33415423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic.
    Mir MA; Kapoor P; Kumar S; Pandey S; Dispenzieri A; Lacy MQ; Dingli D; Hogan W; Buadi F; Hayman S; Gandhi M; Gertz MA
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):349-357.e2. PubMed ID: 25958193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors.
    Kenzik K; Huang IC; Rizzo JD; Shenkman E; Wingard J
    Support Care Cancer; 2015 Mar; 23(3):797-807. PubMed ID: 25193598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Zhang FH; Ling YW; Zhai X; Zhang Y; Huang F; Fan ZP; Zhou HS; Jiang QL; Sun J; Liu QF
    Hematology; 2013 May; 18(3):151-7. PubMed ID: 23394269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.